Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits

  • Nicholas J. Izzo
  • , Agnes Staniszewski
  • , Lillian To
  • , Mauro Fa
  • , Andrew F. Teich
  • , Faisal Saeed
  • , Harrison Wostein
  • , Thomas Walko
  • , Anisha Vaswani
  • , Meghan Wardius
  • , Zanobia Syed
  • , Jessica Ravenscroft
  • , Kelsie Mozzoni
  • , Colleen Silky
  • , Courtney Rehak
  • , Raymond Yurko
  • , Patricia Finn
  • , Gary Look
  • , Gilbert Rishton
  • , Hank Safferstein
    • Miles Miller, Conrad Johanson, Edward Stopa, Manfred Windisch, Birgit Hutter-Paier, Mehrdad Shamloo, Ottavio Arancio, Harry LeVine, Susan M. Catalano

Producción científica: Article › revisión exhaustiva

147 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits'. En conjunto forman una huella única.
Clasificar por

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science